WFA
RMD icon

Wipfli Financial Advisors’s ResMed RMD Stock Holding History

Wipfli Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$312K Buy
+1,428
New +$325K 0.02% 318

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Wipfli Financial Advisors's RMD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in ResMed (RMD) in Q3 2022: 1,428 shares worth $312K. The stake represents 0.02% of the portfolio and ranks #318 among its holdings.

667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Wipfli Financial Advisors held 1,428 shares of ResMed worth $312K as of Q3 2022.
  • ResMed was a new Wipfli Financial Advisors position in Q3 2022.
  • ResMed made up 0.02% of Wipfli Financial Advisors's portfolio in Q3 2022, its #318 holding.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.